inclusion criteria: 1. adult patients (18 years of age or older) with the diagnosis of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection, confirmed via an established standard reverse transcriptase polymerase chain reaction (rt-pcr) assay. 2. patient or patient's legally authorized representative is willing and able to provide informed consent prior to performing any study-related procedures. 3. patient is hospitalized and requires some form of supplemental oxygen, e.g., non-invasive ventilation, high flow oxygen device, or oxygen by mask or nasal cannula. 4. patient has radiographic evidence of pulmonary infiltrate(s) or lung inflammation.

inclusion criteria: 1. adult patients (18 years of age or older) with the diagnosis of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection, confirmed via an established standard reverse transcriptase polymerase chain reaction (rt-pcr) assay. 2. patient or patient's legally authorized representative is willing and able to provide informed consent prior to performing any study-related procedures. 3. patient is hospitalized and requires some form of supplemental oxygen, e.g., non-invasive ventilation, high flow oxygen device, or oxygen by mask or nasal cannula. 4. patient has radiographic evidence of pulmonary infiltrate(s) or lung inflammation.

inclusion criteria: adult patients (18 years of age or older) with the diagnosis of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection, confirmed via an established standard reverse transcriptase polymerase chain reaction (rt-pcr) assay. patient or patient's legally authorized representative is willing and able to provide informed consent prior to performing any study-related procedures. patient is hospitalized and requires some form of supplemental oxygen, e.g., non-invasive ventilation, high flow oxygen device, or oxygen by mask or nasal cannula. patient has radiographic evidence of pulmonary infiltrate(s) or lung inflammation.

inclusion criteria: adult patients (18 years of age or older) with the diagnosis of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection, confirmed via an established standard reverse transcriptase polymerase chain reaction (rt-pcr) assay. patient or patient's legally authorized representative is willing and able to provide informed consent prior to performing any study-related procedures. patient is hospitalized and requires some form of supplemental oxygen, e.g., non-invasive ventilation, high flow oxygen device, or oxygen by mask or nasal cannula. patient has radiographic evidence of pulmonary infiltrate(s) or lung inflammation.

inclusion criteria: 1. adult patients (18 years of age or older) with the diagnosis of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection, confirmed via an established standard reverse transcriptase polymerase chain reaction (rt-pcr) assay. 2. patient or patient's legally authorized representative is willing and able to provide informed consent prior to performing any study-related procedures. 3. patient is hospitalized and requires some form of supplemental oxygen, e.g., non-invasive ventilation, high flow oxygen device, or oxygen by mask or nasal cannula. 4. patient has radiographic evidence of pulmonary infiltrate(s) or lung inflammation.

inclusion criteria: 1. adult patients (18 years of age or older) with the diagnosis of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection, confirmed via an established standard reverse transcriptase polymerase chain reaction (rt-pcr) assay. 2. patient or patient's legally authorized representative is willing and able to provide informed consent prior to performing any study-related procedures. 3. patient is hospitalized and requires some form of supplemental oxygen, e.g., non-invasive ventilation, high flow oxygen device, or oxygen by mask or nasal cannula. 4. patient has radiographic evidence of pulmonary infiltrate(s) or lung inflammation.